Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination

Published:2015-10-26 Issue:12 Volume:64 Page:1609-1621
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Hansen Gaute Lund,Gaudernack Gustav,Brunsvig Paal Fredrik,Cvancarova Milada,Kyte Jon Amund

Funder

Universitetet i Oslo (NO)

Helse Sør-Øst RHF (NO)

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-015-1766-5.pdf

Reference50 articles.

1. Brambilla E, Travis WD (2014) World cancer report. Lung cancer, World Health Organization, Lyon

2. Garon EB, Rizvi NA, Hui R, Leighl N, Balmanoukian AS, Eder JP, Patnaik A, Aggarwal C, Gubens M, Horn L et al (2015) Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med 372(21):2018–2028

3. Melero I, Gaudernack G, Gerritsen W, Huber C, Parmiani G, Scholl S, Thatcher N, Wagstaff J, Zielinski C, Faulkner I et al (2014) Therapeutic vaccines for cancer: an overview of clinical trials. Nat Rev Clin Oncol 11(9):509–524

4. Kyte JA (2009) Cancer vaccination with telomerase peptide GV1001. Expert Opin Investig Drugs 18(5):687–694

5. Bernhardt SL, Gjertsen MK, Trachsel S, Moller M, Eriksen JA, Meo M, Buanes T, Gaudernack G (2006) Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study. Br J Cancer 95(11):1474–1482

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activated B-Cells enhance epitope spreading to support successful cancer immunotherapy;Frontiers in Immunology;2024-03-19

2. Strengthening the Combinational Immunotherapy from Modulating the Tumor Inflammatory Environment via Hypoxia‐Responsive Nanogels;Advanced Healthcare Materials;2023-12-17

3. Landscape of tumor and immune system cells-derived exosomes in lung cancer: mediators of antitumor immunity regulation;Frontiers in Immunology;2023-10-17

4. Improving the efficacy of peptide vaccines in cancer immunotherapy;International Immunopharmacology;2023-10

5. Immune Resistance Mechanisms and the Road to Personalized Immunotherapy;American Society of Clinical Oncology Educational Book;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3